Brach Eichler Talks | Law & Legal Insights from Lawyers

In this episode of the Brach Eichler Talks podcast, Members Lani M. Dornfeld, CHPC, and Jay Sabin discuss one of the most pressing issues facing business leaders today: the unregulated use of artificial intelligence in the workplace. Click here to view the Action Plan now.
With the rapid evolution of technology, there is a widening gap between employee adoption of AI and corporate management. Lani and Jay break down the critical differences between reactive generative AI (like ChatGPT) and proactive agentic AI, which can autonomously execute tasks and pull data from multiple electronic systems. They explore the severe reputational, cyber, and regulatory risks of these tools, sharing real-world examples of AI implementation gone wrong, and explain why guardrails are even more critical with agentic AI.
Tune in to learn how your organization can build effective corporate protections, from enforcing interim policies and educating your workforce to properly vetting vendors and conducting private management briefings.
Need help navigating AI compliance for your organization? Whether you need to develop a holistic AI acceptable use policy, require a detailed review of AI vendor contracts, or need to incorporate AI procedures into your existing HIPAA compliance programs, our team is here to help. Please do not hesitate to contact Lani M. Dornfeld, Esq., CHPC (ldornfeld@bracheichler.com) or Jay Sabin, Esq. (jsabin@bracheichler.com) to kickstart, solidify, enhance, or augment your organization's management of AI.
Subscribe & Follow: Don't forget to subscribe to our podcast on Spotify, Apple Podcasts, and YouTube. Follow us on LinkedIn and Facebook for updates on new episodes. For more information and resources, visit BrachEichler.com.
*This content is intended to provide general information, not legal advice. Please contact Lani or Jay to consult on your organization’s specific AI management needs.

Welcome back to Part 2 of our comprehensive four-part series on "Brach Eichler Talks," breaking down the evolving landscape of New Jersey cannabis laws.
In this episode, we shift focus from the business side (covered in Part 1) to the consumer side. We answer the most frequent questions regarding purchasing, possessing, gifting, and consuming cannabis in the Garden State, ensuring you stay informed and compliant.
Whether you are a recreational user, a medical patient, or a business owner navigating consumer rules, we cover critical details, including:
Purchase Eligibility & Locations: Who can buy (21+) and where (licensed retail vs. medical dispensaries).
Buying Limits: The specific transaction limits for recreational users (1 oz of flower/equivalents) versus medical patients (3 oz/30 days).
Types of Products: The availability of edibles (and what "shelf-stable" means), concentrates, tinctures, and topicals.
Possession Laws: The removal of criminal penalties and the new legal limits (up to 6 oz of marijuana or 17 grams of hashish).
Gifting & Delivery: Is gifting legal? (Yes, up to 1 oz). How delivery services operate and municipal restrictions.
Transportation & State Lines: Important warnings regarding driving with cannabis and the strict prohibition against taking legal cannabis across state lines (federal law).
Odor & Vehicle Searches: Crucial updates on when the odor of cannabis does not constitute reasonable suspicion for a police search.
Where to Consume (and Not Consume): Understanding public consumption prohibitions and navigating rules for private residences, consumption areas, and lodging.
Home Cultivation: The current legal status of growing cannabis plants at home.
Access the Full Guide: Want to read the complete FAQ breakdown? Access the full guide and explore more legal insights by visiting our Cannabis Resource Center: https://www.bracheichler.com/insights/cannabis-laws-in-new-jersey-frequently-asked-questions-2025/
Need Legal Guidance for Your Cannabis Business? Brach Eichler provides sophisticated, cross-discipline legal services tailored specifically to the cannabis industry. If you need help navigating compliance, contact our Cannabis Industry Co-Chairs today:
John D. Fanburg, Managing Member and Co-Chair, Cannabis Law 📞 973.403.3107 | ✉️ jfanburg@bracheichler.com
Charles X. Gormally, Member and Co-Chair, Cannabis Law 📞 973.403.3111 | ✉️ cgormally@bracheichler.com
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice.

In this episode of the Brach Eichler Talks podcast, we break down a critical July 2026 New Jersey Supreme Court decision impacting insurance fraud litigation. The Court ruled that New Jersey Insurance Fraud Prevention Act (IFPA) claims and RICO-based fraud claims are not subject to the personal injury protection (PIP) arbitration process, but instead belong in the Law Division with the right to a jury trial.
Tune in to understand the background of Allstate v. Carteret Comprehensive Medical Care, how this reverses previous trial court decisions, and what this ruling means for pending insurance fraud cases and investigations across New Jersey.
Contact the Attorneys:
Keith J. Roberts, Esq., Member and Chair, Litigation kroberts@bracheichler.com | 973.364.5201
Shannon Carroll, Esq., Member, Litigation scarroll@bracheichler.com | 973.403.3126
Disclaimer: This podcast is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice. For more information and resources, visit bracheichler.com.

In this episode of the Brach Eichler Talks podcast, we discuss a major healthcare law update: the implementation of the Medical Aid in Dying Act (S.138/A.136) in New York State. Signed into law by Governor Hochul, this legislation allows terminally ill, mentally competent adults to self-administer life-ending medication.
We break down the critical components of the Act, including the extensive safeguards, patient eligibility criteria, waiting periods, and the specific protections it offers to healthcare entities and providers. We also cover how the Act addresses life insurance benefits and death certificates ahead of its effective date on August 5, 2026.
Click Here to read the entire June 2026 Healthcare Law Update now!
For more information, contact:Tracy E. Miller | 973.403.3102 | tmiller@bracheichler.com
*This is intended to provide general information, not legal advice. Please contact Tracy if you need specific legal advice.

In this episode of the Brach Eichler Talks podcast, we discuss a crucial healthcare law update regarding New Jersey Governor Mikie Sherrill signing P.L.2026, c.29 into law. This legislation extends telemedicine and telehealth pay parity requirements, ensuring provider reimbursement rates equal in-person rates, from July 1, 2026, through December 31, 2027. Tune in to learn about what this means for behavioral health audio-only services, physical health exclusions, and affected health benefits plans, including Medicaid and NJ FamilyCare.
Click Here to read the entire July 2026 Healthcare Law Update now!
For more information, contact:John D. Fanburg | 973.403.3107 | jfanburg@bracheichler.comEdward Hilzenrath, HLU Editor | 973.403.3114 | ehilzenrath@bracheichler.comErika R. Marshall | 973.364.5236 | emarshall@bracheichler.com
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific advice.

In this episode of Brach Eichler Talks, we dive into the privacy implications of your wearable technology. New Jersey Senate Bill No. 4065 aims to curb the unauthorized sale of sensitive health data collected by smartwatches, fitness trackers, and other devices, shifting the power back to the consumer. We break down what this proposed legislation means for your personal privacy and the future of health data regulation.
📲 Read the entire June 2026 Healthcare Law Update now: https://www.bracheichler.com/healthcare-law-update-june-2026/
To learn more about how this bill could affect you or to discuss specific legal implications, please contact: 
John D. Fanburg, Chair | 973.403.3107 | jfanburg@bracheichler.comEdward Hilzenrath, HLU Editor | 973.403.3114 | ehilzenrath@bracheichler.comErika R. Marshall | 973.364.5236 | emarshall@bracheichler.com
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice.

In this episode, we break down the Federal Trade Commission's latest move to reshape the healthcare landscape: the formation of a new, centralized Healthcare Task Force. We examine how this task force, working in tandem with the DOJ and HHS, aims to sharpen oversight on competition, affordability, and consumer protection. Tune in to understand what this heightened scrutiny means for healthcare transactions and business practices across the industry.
If you have questions about how these emerging regulatory priorities might impact your organization, reach out to the authors of this article from Brach Eichler LLC. You can contact Caroline J. Patterson at https://www.bracheichler.com/professionals/caroline-j-patterson/, Jonathan J. Walzman at https://www.bracheichler.com/professionals/jonathan-j-walzman/, or Rebecca T. Falk at https://www.bracheichler.com/professionals/rebecca-t-falk/ for tailored legal guidance.
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice.

In this episode, we break down the Medicare Advantage Improvement Act of 2026 (H.R. 8375/S. 4384) and what its proposed reforms mean for the healthcare industry. As bipartisan pressure mounts to address concerns over prior authorization delays and retroactive payment denials, our panel examines how this bill aims to standardize utilization management and increase transparency in Medicare Advantage plans.
Join us as we discuss:
The proposed 72-hour turnaround times for standard prior authorization requests.
New mandates for real-time determinations on routine services.
Why the bill prohibits coverage criteria more restrictive than traditional Medicare.
The potential financial and compliance implications for plans failing to meet these new standards.
Whether you are a healthcare provider, administrator, or legal professional, stay informed on how these legislative shifts could impact your operations and patient care delivery. 
📲 Read the full article here: https://www.bracheichler.com/insights/bipartisan-bill-targets-prior-authorization-and-payment-practices-in-medicare-advantage/
For more updates on the evolving healthcare landscape, subscribe to the Brach Eichler Talks podcast. You can read the full June 2026 Healthcare Law Update and reach out to Carol Grelecki, Jonathan J. Walzman, or Paul J. DeMartino, Jr. for additional guidance.
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice.